Phase 2 Results Of The Zuma-3 Study Evaluating Kte-X19, An Anti-Cd19 Chimeric Antigen Receptor T-Cell Therapy, In Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Kte-X19
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 2 Results Of The Zuma-3 Study Evaluating Kte-X19, An Anti-Cd19 Chimeric Antigen Receptor T-Cell Therapy, In Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia ### Output: Kte-X19